← Open Payments lookup

STEPHANIE ELLERBE: Open Payments

NPI 1962834499 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,378 in 179 payments from 13 companies in 2025. Trend: 2023 $1,317 · 2024 $733 · 2025 $3,378

Food & beverage: $3,378
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.24$871
E.R. Squibb & Sons, L.L.C.26$437
Alkermes, Inc.17$346
Teva Pharmaceuticals USA, Inc.22$319
ABBVIE INC.21$282
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$265
Otsuka America Pharmaceutical, Inc.20$248
Vanda Pharmaceuticals Inc.7$153
Lundbeck LLC6$118
Janssen Pharmaceuticals, Inc6$113

Products named: INGREZZA, COBENFY, ARISTADA, REXULTI, VRAYLAR, CAPLYTA, AUSTEDO XR, FANAPT.

Industry payments across FL — which companies pay providers there.